Michael S. Verlander

1.1k total citations
41 papers, 846 citations indexed

About

Michael S. Verlander is a scholar working on Organic Chemistry, Molecular Biology and Microbiology. According to data from OpenAlex, Michael S. Verlander has authored 41 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Organic Chemistry, 21 papers in Molecular Biology and 5 papers in Microbiology. Recurrent topics in Michael S. Verlander's work include Chemical Synthesis and Analysis (18 papers), Synthesis and Reactions of Organic Compounds (6 papers) and Click Chemistry and Applications (5 papers). Michael S. Verlander is often cited by papers focused on Chemical Synthesis and Analysis (18 papers), Synthesis and Reactions of Organic Compounds (6 papers) and Click Chemistry and Applications (5 papers). Michael S. Verlander collaborates with scholars based in United States and Israel. Michael S. Verlander's co-authors include Murray Goodman, William D. Fuller, Leslie E. Orgel, R. Lohrmann, L. Andersson, Martin Flegel, Bo Nilsson, Kenneth L. Melmon, Roberto P. Rosenkranz and Kenneth A. Jacobson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and The Journal of Immunology.

In The Last Decade

Michael S. Verlander

35 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael S. Verlander United States 15 629 284 138 81 78 41 846
Morteza Malakoutikhah Spain 12 386 0.6× 246 0.9× 56 0.4× 23 0.3× 73 0.9× 26 725
J Yang United States 15 458 0.7× 62 0.2× 18 0.1× 97 1.2× 124 1.6× 20 731
Alan J. Kennan United States 15 424 0.7× 208 0.7× 36 0.3× 63 0.8× 27 0.3× 23 604
Erik B. Hadley United States 9 480 0.8× 224 0.8× 10 0.1× 28 0.3× 21 0.3× 13 552
Michael Griffith United States 9 1.2k 2.0× 316 1.1× 10 0.1× 75 0.9× 65 0.8× 18 1.4k
A. Previeŕo France 17 586 0.9× 146 0.5× 6 0.0× 134 1.7× 124 1.6× 63 828
Vibin Ramakrishnan India 16 433 0.7× 105 0.4× 8 0.1× 34 0.4× 36 0.5× 56 643
Lilach Vaks Israel 7 334 0.5× 92 0.3× 7 0.1× 49 0.6× 49 0.6× 9 560
G. King United States 13 749 1.2× 235 0.8× 6 0.0× 82 1.0× 132 1.7× 14 1.0k
Takahito Mukai Japan 19 1.1k 1.7× 164 0.6× 8 0.1× 28 0.3× 19 0.2× 32 1.2k

Countries citing papers authored by Michael S. Verlander

Since Specialization
Citations

This map shows the geographic impact of Michael S. Verlander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Verlander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Verlander more than expected).

Fields of papers citing papers by Michael S. Verlander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Verlander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Verlander. The network helps show where Michael S. Verlander may publish in the future.

Co-authorship network of co-authors of Michael S. Verlander

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Verlander. A scholar is included among the top collaborators of Michael S. Verlander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Verlander. Michael S. Verlander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Verlander, Michael S.. (2003). Large‐Scale Manufacturing Methods for Peptides: A Status Report. ChemInform. 34(36). 3 indexed citations
3.
Verlander, Michael S.. (2001). Solid-Phase Synthesis:  A Practical Guide Edited by S. A. Kates and F. Albericio. Marcel Dekker:  New York. 2000. 826 pp. $250. ISBN 0-8247-0359-6.. Organic Process Research & Development. 5(6). 667–668. 1 indexed citations
4.
Andersson, L., et al.. (2000). Large-scale synthesis of peptides. Biopolymers. 55(3). 227–250. 147 indexed citations
5.
Khan, Manzoor M., et al.. (1987). In vitro pharmacologic activity of congener derivatives and model conjugates of propranolol and practolol. Biochemical Pharmacology. 36(13). 2175–2182. 2 indexed citations
6.
Verlander, Michael S., et al.. (1987). Conjugates of catecholamines. VII. Synthesis and β‐adrenergic activity of peptide catecholamine conjugates†. International journal of peptide & protein research. 29(3). 300–317. 2 indexed citations
7.
Khan, Manzoor M., et al.. (1987). Congener derivatives and conjugates of histamine: synthesis and tissue and receptor selectivity of the derivatives. Journal of Medicinal Chemistry. 30(11). 2115–2120. 14 indexed citations
8.
Schramm, Michael, Sara Eimerl, Murray Goodman, et al.. (1986). High potency congeners of isoproterenol. Biochemical Pharmacology. 35(16). 2805–2809. 4 indexed citations
9.
Reitz, Allen B., Mitchell A. Avery, Roberto P. Rosenkranz, et al.. (1985). Conjugates of Catecholamines. 6. Synthesis and β-Adrenergic Activity of N - (Hydroxyalkyl)catecholamine Derivatives. Journal of Medicinal Chemistry. 28(5). 642–647. 6 indexed citations
10.
Sigler, Gerald F., et al.. (1983). Formation of oligopeptides during the synthesis of 9‐fluorenylmethyloxycarbonyl amino acid derivatives. Biopolymers. 22(10). 2157–2162. 57 indexed citations
11.
Rosenkranz, Roberto P., Brian B. Hoffman, Kenneth A. Jacobson, et al.. (1983). Conjugates of catecholamines. II. In vitro and in vivo pharmacological activity of N-alkyl-functionalized carboxylic acid congeners and amides related to isoproterenol.. Molecular Pharmacology. 24(3). 429–435. 10 indexed citations
12.
Verlander, Michael S., Kenneth A. Jacobson, Roberto P. Rosenkranz, Kenneth L. Melmon, & Murray Goodman. (1983). Some novel approaches to the design and synthesis of peptide–catecholamine conjugates. Biopolymers. 22(1). 531–545. 11 indexed citations
13.
Rosenkranz, Roberto P., et al.. (1983). Conjugates of catecholamines. IV. In vitro and in vivo pharmacological activity of monodisperse oligopeptide conjugates.. Journal of Pharmacology and Experimental Therapeutics. 227(2). 267–273. 15 indexed citations
14.
Jacobson, Kenneth A., et al.. (1982). In vitro and in vivo betamimetic activity of congeners of isoproterenol.. PubMed. 25. 19–23.
15.
Sakarellos‐Daitsiotis, Maria, Michael S. Verlander, Russell F. Doolittle, & Murray Goodman. (1978). Synthesis and thrombolytic properties of some flufenamate derivatives. Thrombosis Research. 12(4). 707–711. 1 indexed citations
16.
Fuller, William D., Michael S. Verlander, & Murray Goodman. (1978). DOPA‐containing polypeptides. I. Improved synthesis of high‐molecular‐weight poly(L‐DOPA) and water‐soluble copolypeptides. Biopolymers. 17(12). 2939–2943. 17 indexed citations
17.
Pierre, S. St., R. T. Ingwall, Michael S. Verlander, & Murray Goodman. (1978). Conformational studies of sequential polypeptides containing lysine and tyrosine. Biopolymers. 17(8). 1837–1848. 25 indexed citations
18.
Verlander, Michael S., J. Craig Venter, Murray Goodman, Nathan O. Kaplan, & Benjamin R. Saks. (1976). Biological activity of catecholamines covalently linked to synthetic polymers: proof of immobilized drug theory.. Proceedings of the National Academy of Sciences. 73(4). 1009–1013. 24 indexed citations
19.
Fuller, William D., Michael S. Verlander, & Murray Goodman. (1976). A procedure for the facile syntheis of amino‐acid N‐carboxyanhydrides. Biopolymers. 15(9). 1869–1871. 124 indexed citations
20.
Acheson, R. M. & Michael S. Verlander. (1969). Addition reactions of heterocyclic compounds. Part XL. Methyl propiolate with some quinolines, isoquinolines, and phenanthridines. Journal of the Chemical Society C Organic. 2311–2311.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Morteza Malakoutikhah Breakdown of academic impact, for papers by J Yang Breakdown of academic impact, for papers by Alan J. Kennan Breakdown of academic impact, for papers by Erik B. Hadley Breakdown of academic impact, for papers by Michael Griffith Breakdown of academic impact, for papers by A. Previeŕo Breakdown of academic impact, for papers by Vibin Ramakrishnan Breakdown of academic impact, for papers by Lilach Vaks Breakdown of academic impact, for papers by G. King Breakdown of academic impact, for papers by Takahito Mukai
Rankless by CCL
2026